Lyra Therapeutics, Inc. Annual Operating Margin in % from 2021 to 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Lyra Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from 2021 to 2024.
  • Lyra Therapeutics, Inc. Operating Margin for the quarter ending December 31, 2024 was -6.28K %, a 45.8% decline year-over-year.
  • Lyra Therapeutics, Inc. annual Operating Margin for 2024 was -6.28K %, a 45.8% decline from 2023.
  • Lyra Therapeutics, Inc. annual Operating Margin for 2023 was -4.31K %, a 4.29% decline from 2022.
  • Lyra Therapeutics, Inc. annual Operating Margin for 2022 was -4.13K %, a 73% increase from 2021.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2024 -6.28K -1.97K -45.8% Jan 1, 2024 Dec 31, 2024
2023 -4.31K -177 -4.29% Jan 1, 2023 Dec 31, 2023
2022 -4.13K +11.2K +73% Jan 1, 2022 Dec 31, 2022
2021 -15.3K Jan 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.